Paul J. Thuluvath mainly investigates Internal medicine, Liver transplantation, Gastroenterology, Surgery and Transplantation. The concepts of his Internal medicine study are interwoven with issues in Diabetes mellitus and Endocrinology. His Liver transplantation study integrates concerns from other disciplines, such as Bilirubin, Proportional hazards model and Sepsis.
His studies in Gastroenterology integrate themes in fields like Daclatasvir, Ribavirin, Immunology and Primary sclerosing cholangitis, Disease. His study explores the link between Surgery and topics such as Hazard ratio that cross with problems in Independent predictor, Cohort study, Orthotopic liver transplantation and Cause of death. His research in Transplantation intersects with topics in Liver disease and Hepatocellular carcinoma.
Paul J. Thuluvath mainly focuses on Internal medicine, Gastroenterology, Liver transplantation, Cirrhosis and Surgery. His work in the fields of Internal medicine, such as Liver disease, Hepatology, Hepatitis C and Hepatocellular carcinoma, intersects with other areas such as In patient. His research investigates the connection between Gastroenterology and topics such as Ribavirin that intersect with problems in Regimen.
His work focuses on many connections between Liver transplantation and other disciplines, such as Proportional hazards model, that overlap with his field of interest in Confounding. His Cirrhosis study incorporates themes from Prospective cohort study, Dialysis and Cohort. His Surgery study combines topics from a wide range of disciplines, such as Odds ratio and Hazard ratio.
Paul J. Thuluvath focuses on Internal medicine, Cirrhosis, Gastroenterology, Cohort and Liver disease. Paul J. Thuluvath undertakes multidisciplinary investigations into Internal medicine and In patient in his work. His Cirrhosis research integrates issues from Dialysis, Cohort study, Emergency medicine and Intensive care medicine.
His work carried out in the field of Gastroenterology brings together such families of science as Acute kidney injury and Patient survival. His work in Cohort tackles topics such as Hepatic encephalopathy which are related to areas like Hepatology, Metabolite and Area under the curve. Paul J. Thuluvath combines subjects such as Liver function, Liver transplantation, Model for End-Stage Liver Disease, Steatohepatitis and Severity of illness with his study of Liver disease.
Cirrhosis, Internal medicine, Gastroenterology, Portal hypertension and Liver disease are his primary areas of study. His study looks at the relationship between Cirrhosis and topics such as Cohort study, which overlap with Pharmacotherapy, Lactulose and Cohort. Paul J. Thuluvath conducts interdisciplinary study in the fields of Internal medicine and Sleep deprivation through his research.
Gastroenterology connects with themes related to Dialysis in his study. In his study, Randomized controlled trial, Nonalcoholic fatty liver disease, Esophageal varices and Varices is inextricably linked to Placebo, which falls within the broad field of Portal hypertension. His research integrates issues of Liver transplantation, Kidney disease, Renal function, Creatinine and Acute kidney injury in his study of Liver disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection
Mark S. Sulkowski;David F. Gardiner;Maribel Rodriguez-Torres;K. Rajender Reddy.
The New England Journal of Medicine (2014)
All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study
David R. Nelson;James N. Cooper;Jacob P. Lalezari;Eric Lawitz.
Liver Transplantation in the United States, 1999–2008
P. J. Thuluvath;M. K. Guidinger;J. J. Fung;L. B. Johnson.
American Journal of Transplantation (2010)
Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study
Asma Poonawala;Satheesh P. Nair;Paul J. Thuluvath.
Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation.
Satheesh Nair;Sumita Verma;Paul J. Thuluvath.
Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States.
Satheesh Nair;Sumita Verma;Paul J. Thuluvath;Paul J. Thuluvath.
SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma
Andrew X. Zhu;Olivier Rosmorduc;T. R Jeffry Evans;Paul J. Ross.
Journal of Clinical Oncology (2015)
A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: A multicenter, randomized, placebo-controlled trial
Florence Wong;Andres T. Blei;Laurence M. Blendis;Paul J. Thuluvath.
Acute hepatitis C
Anurag Maheshwari;Stuart Ray;Paul J Thuluvath.
The Lancet (2008)
MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3
Florin M. Selaru;Alexandru V. Olaru;Takatsugu Kan;Stefan David.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: